AKBA - Akebia Therapeutics, Inc.
1.19
-0.060 -5.042%
Share volume: 2,836,810
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$1.25
-0.06
-0.05%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-08-2024 | 11-07-2024 | 03-13-2025 | 05-08-2025 | 08-07-2025 | 11-10-2025 | 02-26-2026 | |
| Cash flow financing | 18.475 M | 7.640 M | 1.223 M | 22.325 M | 74.942 M | 1.720 M | 1.113 M | -4.848 M | |
| Other financing cash flows | 141.000 K | 14.000 K | 0.000 | 230.000 K | 482.000 K | 178.000 K | 961.000 K | -4.848 M | |
| Cash flow | -957.000 K | -2.455 M | -5.474 M | 17.857 M | 61.509 M | 23.939 M | 29.141 M | 18.404 M | |
| Net income | -17.985 M | -8.582 M | -20.039 M | -22.804 M | 6.112 M | 247.000 K | 540.000 K | -12.244 M | |
| Depreciation | 364.000 K | 400.000 K | 363.000 K | 335.000 K | 314.000 K | 316.000 K | 318.000 K | 321.000 K | |
| Changes in inventories | 4.434 M | 0.000 | 0.000 | 0.000 | 4.953 M | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | -29.000 K | -2.000 K | -2.000 K | 154.000 K | -126.000 K | -77.000 K | -7.877 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 2.000 K | 2.000 K | -154.000 K | 126.000 K | 77.000 K | 70.000 K | |
| Cash Change | -957.000 K | -2.455 M | -5.474 M | 17.857 M | 61.509 M | 23.939 M | 29.141 M | 18.404 M |